Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.)

Scopus

Scopus profile and journal metrics

This journal is indexed in Scopus. Use these metrics for a quick publishing snapshot, then open the Scopus page for the authoritative profile.

Scopus
Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) Indexed in Scopus since 2022
CiteScore 1.0
Indexed since 2022
First decision 7 Days
Submission to acceptance 45 Days
Acceptance to publication 14 Days
Acceptance rate 8%

SCImago

SCImago Journal Rank preview

Use SCImago when you want a quick visual view of the journal ranking profile and external discoverability signals.

Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) SCImago Journal & Country Rank

DOAJ

Directory of Open Access Journals listing

The DOAJ record is useful for readers, librarians, and authors who want a direct open-access directory entry for the journal.

DOAJ
Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) Open directory record
Original full research article

Lower Urinary Tract Symptoms and Quality of Life Among Female Hemodialysis Patients in Palestine: Prevalence and Risk Factors

Published
2024-11-11
Pages
35 - 40
Full text

Keywords

  • Quality of Life
  • Hemodialysis
  • risk factors
  • female patients.
  • Lower urinary tract symptoms (LUT)

Abstract

Introduction: Lower urinary tract symptoms (LUTS) are prevalent globally. Limited research has explored LUTS in hemodialysis (HD) patients, who often experience diminished quality of life (QoL). This study aims to evaluate LUTS among female HD patients, with assessment of the symptom, risk factors, and impact on QoL. Methods: A prospective, cross-sectional study was conducted among 94 female HD patients, assessing demographics, clinical data, and LUTS using the Bristol Female Lower Urinary Tract Symptoms (BFLUTS) questionnaire. Statistical analysis examined correlations between BFLUTS, demographics, and QoL. Results: Among the study population, 91.5% of female HD patients experienced at least one filling symptom, with the most common being nocturia (65%, n = 61). Voiding symptoms were observed in 63% of participants, with hesitancy (49%, n = 46), straining (33%, n = 31), and intermittency (45%, n = 42) being notable. Incontinence symptoms were prevalent, with urgency incontinence reported by 23% of participants (n = 22). Statistically significant correlations were found between the duration of dialysis and voiding symptoms (r = 0.240, p = 0.021), as well as between poor QoL and storage symptoms (r = 0.212, p = 0.040) and incontinence symptoms (r = 0.439, p < 0.001). Additionally, significant associations were found between the presence of incontinence symptoms and diabetes mellitus (p = 0.002) and smoking (p = 0.042). Conclusion: The impact of LUTS on females undergoing HD is prevalent and should be considered as disabling syndrome. The QoL in such cohort of patients is also affected. Thus, screening protocols should be put in place to address such problem.

Article history

Received
2024-04-20
Accepted
2024-06-17
Available online
2024-11-11
بحث أصيل كامل

Lower Urinary Tract Symptoms and Quality of Life Among Female Hemodialysis Patients in Palestine: Prevalence and Risk Factors

Published
2024-11-11
الصفحات
35 - 40
البحث كاملا

الكلمات الإفتتاحية

  • Quality of Life
  • Hemodialysis
  • risk factors
  • female patients.
  • Lower urinary tract symptoms (LUT)

الملخص

Introduction: Lower urinary tract symptoms (LUTS) are prevalent globally. Limited research has explored LUTS in hemodialysis (HD) patients, who often experience diminished quality of life (QoL). This study aims to evaluate LUTS among female HD patients, with assessment of the symptom, risk factors, and impact on QoL. Methods: A prospective, cross-sectional study was conducted among 94 female HD patients, assessing demographics, clinical data, and LUTS using the Bristol Female Lower Urinary Tract Symptoms (BFLUTS) questionnaire. Statistical analysis examined correlations between BFLUTS, demographics, and QoL. Results: Among the study population, 91.5% of female HD patients experienced at least one filling symptom, with the most common being nocturia (65%, n = 61). Voiding symptoms were observed in 63% of participants, with hesitancy (49%, n = 46), straining (33%, n = 31), and intermittency (45%, n = 42) being notable. Incontinence symptoms were prevalent, with urgency incontinence reported by 23% of participants (n = 22). Statistically significant correlations were found between the duration of dialysis and voiding symptoms (r = 0.240, p = 0.021), as well as between poor QoL and storage symptoms (r = 0.212, p = 0.040) and incontinence symptoms (r = 0.439, p < 0.001). Additionally, significant associations were found between the presence of incontinence symptoms and diabetes mellitus (p = 0.002) and smoking (p = 0.042). Conclusion: The impact of LUTS on females undergoing HD is prevalent and should be considered as disabling syndrome. The QoL in such cohort of patients is also affected. Thus, screening protocols should be put in place to address such problem.

Article history

تاريخ التسليم
2024-04-20
تاريخ القبول
2024-06-17
Available online
2024-11-11